James Simon
Gynecology · Washington, DCNPI 1700947256
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $497,732 of the $811,209 with a category attached, or 61.4%. 40 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 40.4% of the total.
Across 810 payments — averaging $1001.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$328K
- AbbVie$104K
- Therapeuticsmd, Inc.$81K
- Bayer$79K
- AMAG Pharmaceuticals, Inc.$42K
- Astellas Pharma US Inc$38K
- plus $138K from 34 others
Across 389 payments — averaging $3131.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$650K
- Sumitomo Pharma America, Inc.$236K
- Bayer$156K
- Mylan Inc.$107K
- Myovant Sciences GmbH$33K
- Mylan Technologies Inc.$28K
- plus $9K from 3 others
What the payments were for
- Consulting fees$185,12823%
- Speaking & faculty fees$497,73261%
- Travel & lodging$101,91713%
- Food & beverage$25,5543%
- Education$8570%
- Gifts$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXTSTELLIS$242,814
- BIJUVA$82,498
- ANNOVERA$80,124
- Orilissa$72,901
- Veozah$37,755
- IMVEXXY$32,862
- Essure$27,000
- MYFEMBREE$21,823
- INTRAROSA$16,959
- MAKENA$14,605
- ESTROGEL$13,500
- Vagifem$9,100
- Tymlos$7,676
- Osphena$7,387
- ORIAHNN$5,800
- VYLEESI$4,877
- Non-Covered$3,099
- AIMOVIG$3,000
- MOLECULAR DIAGNOSTICS RESEARCH & DEVELOPMENT$2,700
- Lynkuet$2,261
How this compares
Too few gynecology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 84 | $15,486 |
| Estradiol (Twice Weekly)Estradiol | 123 | $14,180 |
| PremarinEstrogens, Conjugated | 26 | $13,206 |
| FemringEstradiol Acetate | 13 | $9,860 |
| YuvafemEstradiol | 39 | $8,239 |
| ProgesteroneProgesterone, Micronized | 125 | $6,587 |
| ValacyclovirValacyclovir Hcl | 26 | $1,655 |
| Estradiol (Once Weekly)Estradiol | 11 | $1,458 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 16 | $1,456 |
| DottiEstradiol | 13 | $1,200 |
| Escitalopram Oxalate | 13 | $473 |
| Clobetasol Propionate | 13 | $387 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $309 |
| Fluconazole | 24 | $192 |
| Acyclovir | 14 | $190 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $17,597 | $13,20626 claims |
| Millicent US IncFemring | $197 | $9,86013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few gynecology providers in District of Columbiaon file to place this against a meaningful peer group, so we don't.
Other gynecology in Washington
- Gaby MoawadWashington$1.5M
- Anthony ScialliWashington$165K
- Andrew GoldsteinWashington$156K
- Marilyn JeromeWashington$14K
- Erica DavenportWashington$13K
- Julian SafranWashington$6K
- Sharon MaloneWashington$3K
- Alyssa Small LayneWashington$3K
- Bandhana BajajWashington$2K
- George SammanWashington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.